Dr. Gregory Roth receives NHLBI R01 Grant
The NIH Research Project Grant Program, otherwise known as R01, is the oldest grant mechanism used by NIH. The probability of receiving an R01 for one’s application was under 20% in 2017, and even then the amounts awarded vary. To receive a R01 is a huge honor for research labs across the nation hoping to put their proposals into action. Currently, the University of Washington stands amongst the top 15 NIH Awarded institutions in the nation, with 700+ awards over the past year.
Dr. Gregory Roth has just added to that.
With a newly awarded 5 year, $2.7 million grant, Dr. Roth is ready to continue his study titled the Impact of Interventions of Future Trends in Subnational Burden of Cardiovascular Diseases in the US. Through the study, Dr. Roth will be examining the cardiovascular health disparities by age, sex, state, and race in the US, while comparing the future impact of public health and clinical interventions to reduce athersclerotic vascular disease by developing new tools for health forecasting and population simulation.
Join us on congratulating Dr. Gregory Roth on receiving this grant!
About Gregory Roth, MD, MPH
Gregory Roth, M.D., M.P.H., is an assistant professor in the Division of Cardiology at the University of Washington. His expertise is in general cardiology, cardiac critical care and echocardiography (heart ultrasound imaging). He works at Harborview Medical Center's Cardiology Clinic and is an attending physician for the Harborview Cardiac Care Unit and Cardiology Consultative Service. He also is an attending physician at Harborview's Echocardiography Laboratory. His research focuses on global health surveillance, population health and cardiovascular quality and outcomes. He is a visiting faculty member at the UW Institute for Health Metrics and Evaluation.
Dr. Roth earned his bachelor's and medical degrees from Brown University. He trained in internal medicine and cardiovascular medicine at the UW and served as an attending physician in the emergency department at Harborview Medical Center, Seattle, and as a consultant physician at Whakatane Hospital, New Zealand. He received additional training as a post-doctoral fellow with the Veterans Administration Health Services Research and Development branch.
Dr. Roth is a recipient of an American Heart Association post-doctoral fellowship for his work developing a pharmacokinetic approach to measuring treatment disparities in heart failure. He is also the recipient of a UW Institute for Translational Health Sciences Ignition research grant for his work examining pharmacogenomics in heart failure. He is an associate editor for the journal, Global Heart. In his spare time, Dr. Roth enjoys spending time with his family.